Search Results - "Castro, Valeriana Di"

Refine Results
  1. 1
  2. 2

    Endothelin-1 Stimulates Lymphatic Endothelial Cells and Lymphatic Vessels to Grow and Invade by SPINELLA, Francesca, GARRAFA, Emirena, DI CASTRO, Valeriana, ROSANO, Laura, RITA NICOTRA, Maria, CARUSO, Arnaldo, GIORGIO NATALI, Pier, BAGNATO, Anna

    Published in Cancer research (Chicago, Ill.) (15-03-2009)
    “…The lymphatic vasculature is essential for tissue fluid homeostasis and cancer metastasis, although the molecular mechanisms involved remain poorly…”
    Get full text
    Journal Article
  3. 3

    Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo by Salani, Debora, Taraboletti, Giulia, Rosanò, Laura, Di Castro, Valeriana, Borsotti, Patrizia, Giavazzi, Raffaella, Bagnato, Anna

    Published in The American journal of pathology (01-11-2000)
    “…The endothelial cell-derived endothelin-1 (ET-1) is a potent mitogen for endothelial cells, vascular smooth muscle cells, and tumor cells. In this study, we…”
    Get full text
    Journal Article
  4. 4

    Role of Endothelin-1 in Neovascularization of Ovarian Carcinoma by Salani, Debora, Di Castro, Valeriana, Nicotra, Maria Rita, Rosanò, Laura, Tecce, Raffaele, Venuti, Aldo, Natali, Pier Giorgio, Bagnato, Anna

    Published in The American journal of pathology (01-11-2000)
    “…Endothelin-1 (ET-1) is overexpressed in ovarian carcinomas and acts, via ET A receptors (ET AR), as an autocrine growth factor. In this study we investigate…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer by Sestito, Rosanna, Tocci, Piera, Roman, Celia, Di Castro, Valeriana, Bagnato, Anna

    “…Epithelial-to-mesenchymal transition (EMT) encompasses a highly dynamic and complex key process which leads to metastatic progression. In high-grade serous…”
    Get full text
    Journal Article
  7. 7

    Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition by Tocci, Piera, Roman, Celia, Sestito, Rosanna, Di Castro, Valeriana, Sacconi, Andrea, Molineris, Ivan, Paolini, Francesca, Carosi, Mariantonia, Tonon, Giovanni, Blandino, Giovanni, Bagnato, Anna

    Published in Cell death & disease (05-01-2023)
    “…PARP inhibitors (PARPi) have changed the treatment paradigm of high-grade serous ovarian cancer (HG-SOC). However, the impact of this class of inhibitors in…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis by Sestito, Rosanna, Cianfrocca, Roberta, Rosanò, Laura, Tocci, Piera, Di Castro, Valeriana, Caprara, Valentina, Bagnato, Anna

    Published in Life sciences (1973) (15-08-2016)
    “…In epithelial ovarian cancer (EOC), activation of endothelin-1 (ET-1)/endothelin A receptor (ETAR) and ET-1/ETBR signaling is linked to many tumor promoting…”
    Get full text
    Journal Article
  10. 10

    Endothelin-1 Inhibits Prolyl Hydroxylase Domain 2 to Activate Hypoxia-Inducible Factor-1α in Melanoma Cells by Spinella, Francesca, Rosanò, Laura, Del Duca, Martina, Di Castro, Valeriana, Nicotra, Maria Rita, Natali, Pier Giorgio, Bagnato, Anna

    Published in PloS one (21-06-2010)
    “…Background The endothelin B receptor (ETBR) promotes tumorigenesis and melanoma progression through activation by endothelin (ET)-1, thus representing a…”
    Get full text
    Journal Article
  11. 11

    Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells by ROSANO, Laura, SPINELLA, Francesca, DI CASTRO, Valeriana, NICOTRA, Maria Rita, DEDHAR, Shoukat, GARCIA DE HERREROS, Antonio, GIORGIO NATALI, Pier, BAGNATO, Anna

    Published in Cancer research (Chicago, Ill.) (15-12-2005)
    “…Despite considerable efforts to improve early detection and advances in chemotherapy, metastatic relapses remain a major challenge in the management of ovarian…”
    Get full text
    Journal Article
  12. 12

    Endothelin-1-induced Prostaglandin E2-EP2, EP4 Signaling Regulates Vascular Endothelial Growth Factor Production and Ovarian Carcinoma Cell Invasion by Spinella, Francesca, Rosanò, Laura, Di Castro, Valeriana, Natali, Pier Giorgio, Bagnato, Anna

    Published in The Journal of biological chemistry (05-11-2004)
    “…Cyclooxygenase (COX)-1- and COX-2-derived prostaglandins are implicated in the development and progression of several malignancies. We have recently…”
    Get full text
    Journal Article
  13. 13

    ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo by Rosanò, Laura, Di Castro, Valeriana, Spinella, Francesca, Nicotra, Maria Rita, Natali, Pier Giorgio, Bagnato, Anna

    Published in Molecular cancer therapeutics (01-07-2007)
    “…The autocrine endothelin (ET)-1/endothelin A receptor (ET A R) pathway is an important regulator of several processes involved in ovarian cancer progression,…”
    Get full text
    Journal Article
  14. 14

    Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression by BAGNATO, Anna, ROSANO, Laura, SPINELLA, Francesca, DI CASTRO, Valeriana, TECCE, Raffaele, NATALI, Pier Giorgio

    Published in Cancer research (Chicago, Ill.) (15-02-2004)
    “…Phenotypic and genotypic analyses of cutaneous melanoma have identified the endothelin B receptor (ET(B)R) as tumor progression marker, thus representing a…”
    Get full text
    Journal Article
  15. 15

    Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation by Del Bufalo, Donatella, Di Castro, Valeriana, Biroccio, Annamaria, Varmi, Marco, Salani, Debora, Rosanò, Laura, Trisciuoglio, Daniela, Spinella, Francesca, Bagnato, Anna

    Published in Molecular pharmacology (01-03-2002)
    “…Endothelin-1 (ET-1) is a powerful mitogenic peptide produced by different tumors. In ovarian carcinoma cells, ET-1 acts as an autocrine growth factor,…”
    Get more information
    Journal Article
  16. 16

    Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma by Rosanò, Laura, Spinella, Francesca, Di Castro, Valeriana, Dedhar, Shoukat, Nicotra, Maria Rita, Natali, Pier Giorgio, Bagnato, Anna

    Published in Molecular cancer therapeutics (01-04-2006)
    “…The endothelin-1 (ET-1) axis represents a novel target in several malignancies, including ovarian carcinoma. Upon being activated, the endothelin A receptor…”
    Get full text
    Journal Article
  17. 17

    Endothelin axis induces metalloproteinase activation and invasiveness in human lymphatic endothelial cells by Spinella, Francesca, Caprara, Valentina, Garrafa, Emirena, Di Castro, Valeriana, Rosanò, Laura, Natali, Pier Giorgio, Bagnato, Anna

    “…The molecular mechanisms involved in lymphangiogenesis were unknown until recently. We previously demonstrated that the endothelin-1 (ET-1) axis stimulates…”
    Get more information
    Journal Article
  18. 18

    Endothelin-1 Decreases Gap Junctional Intercellular Communication by Inducing Phosphorylation of Connexin 43 in Human Ovarian Carcinoma Cells by Spinella, Francesca, Rosanò, Laura, Di Castro, Valeriana, Nicotra, Maria Rita, Natali, Pier Giorgio, Bagnato, Anna

    Published in The Journal of biological chemistry (17-10-2003)
    “…Endothelin-1 (ET-1) is overexpressed in ovarian carcinoma and acts as an autocrine factor selectively through the ETA receptor (ETAR) to promote tumor cell…”
    Get full text
    Journal Article
  19. 19

    Inhibition of Cyclooxygenase-1 and -2 Expression by Targeting the Endothelin A Receptor in Human Ovarian Carcinoma Cells by SPINELLA, Francesca, ROSANO, Laura, DI CASTRO, Valeriana, NICOTRA, Maria Rita, NATALI, Pier Giorgio, BAGNATO, Anna

    Published in Clinical cancer research (15-07-2004)
    “…Purpose and Experimental Design: New therapies against cancer are based on targeting cyclooxygenase (COX)-2. Activation of the endothelin A receptor (ET A R)…”
    Get full text
    Journal Article
  20. 20